Searched for: in-biosketch:true
person:boydl01
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity
Wang, Feng-qiang; Ariztia, Edgardo V; Boyd, Leslie R; Horton, Faith R; Smicun, Yoel; Hetherington, Jessica A; Smith, Phillip J; Fishman, David A
OBJECTIVES: Lysophosphatidic acid (LPA) has potent growth-regulatory effect in many cell types and has been linked to the in vivo tumor growth and metastasis in several malignancies. The goal of this study was to assess the regulation of (EC) microenvironment by LPA through the examination of its effect on cell proliferation, migration, invasion, uPA activity, and matrix metalloproteinase (MMP) secretion/activation. METHODS: All experiments were performed in vitro using an EC cell line, HEC-1A. Cell proliferation was determined using the Promega MTS proliferation assay following 48 h of exposures to different concentrations of LPA (0.1, 1.0 and 10.0 microM). Cell invasion was assessed using a modified Boyden chamber assay with collagen I coated on the membrane. HEC-1A motility was examined by Boyden chamber migration assay as well as the scratch wound closure assay on type I collagen. MMP secretion/activation in HEC-1A conditioned medium was detected by gelatin zymography. MMP-7 mRNA expression was determined using real-time PCR. uPA activity was measured using a coupled colorimetric assay. RESULTS: LPA, at the concentrations of 0.1 and 1.0 microM, significantly induced the proliferation of HEC-1A cells (p<0.01). At 10 microM, LPA- induced HEC-1A proliferation to a less extent and showed no significant effect on HEC-1A invasion and migration (p>0.05). Gelatin zymogram showed that HEC-1A cells secreted high levels of MMP-7, while MMP-2 and MMP-9 are barely detectable. In addition, LPA significantly enhanced uPA activity in HEC-1A conditioned medium in a concentration-dependent manner. CONCLUSIONS: LPA is a potent modulator of cellular proliferation and invasion for EC cells. It also has the capacity to stimulate the secretion/activity of uPA and MMP-7. Those results suggest that LPA is a bioactive modulator of EC microenvironment and may have a distinct regulation mechanism as observed in epithelial ovarian cancer
PMID: 20056268
ISSN: 1095-6859
CID: 133487
A comparison of postoperative pain between robotic and laparoscopic gynecologic surgery [Meeting Abstract]
Ferrante, K; Novetsky, A; Pua, T; Jain, R; Boyd, L; Blank, S; Curtin, J; Pothuri, B
ISI:000277538000372
ISSN: 0090-8258
CID: 111930
Intraperitoneal chemotherapy: Who, what, when, and how in diverse academic settings [Meeting Abstract]
Boyd, LR; Novetsky, A; Pua, TL; Pothuri, B; Curtin, JP; Wallach, RC; Blank, SV
ISI:000208852004169
ISSN: 1527-7755
CID: 2142202
Ovarian cancer treatment in the New York City municipal hospital system [Meeting Abstract]
Boyd, L. R.; Novetsky, A. P.; Curtin, J. P.
ISI:000276606600070
ISSN: 0732-183x
CID: 3159072
Epidemiology and treatment of cervical cancer cases in a private versus public hospital setting [Meeting Abstract]
Boyd, LR; Pua, TL; Novetsky, AP; Pothuri, B; Curtin, JP; Hope, JM; Wallach, RC; Fishman, DA; Blank, SV
ISI:000264230200084
ISSN: 0090-8258
CID: 97670
Lysophosphatidic acid receptor-2 mediates lysophosphatidic acid-induced endometrial cancer invasion [Meeting Abstract]
Hope, JM; Wang, F; Whyte, JS; Boyd, LR; Ariztia, EV; Long, K; Fishman, DA
ISI:000264230200157
ISSN: 0090-8258
CID: 97673
Outcomes of endometrial cancer cases in a private versus public hospital setting [Meeting Abstract]
Pua, TL; Boyd, LR; Novetsky, AP; Garcia, L; Devine, K; Curtin, JP; Pothuri, B; Hope, JM; Wallach, RC; Fishman, DA; Blank, SV
ISI:000264230200165
ISSN: 0090-8258
CID: 97674
Pegylated liposomal doxorubicin (PLD) with bevacizumab (B) in second-line treatment of ovarian cancer (OC): Pharmacokinetics (PK), safety, and preliminary outcome results [Meeting Abstract]
Muggia, FM; Boyd, L; Liebes, L; Downey, A; Muller, C; Pothuri, B; Blank, S; Rutledge, T; Fishman, D; Verschraegen, C
ISI:000276606600049
ISSN: 0732-183x
CID: 2142242
Endometrial cancer cells treated with lysophosphatidic acid increase activation of matrix metalloproteinase 2 [Meeting Abstract]
Boyd, LR; Ariztia, EV; Mayer-Hope, J; Fishman, DA
ISI:000253822200202
ISSN: 0090-8258
CID: 76431
Endometrial cancer cells produce proinvasive vesicles [Meeting Abstract]
Boyd, LR; Mayer-Hope, J; Ariztia, EV; Fishman, DA
ISI:000253822200171
ISSN: 0090-8258
CID: 76430